Assorted News from the Last Week: A recent study indicates that children and young adults with cancer face an elevated risk of dying if they

Assorted News from the Last Week: A large number of CAC2 members contributed to the recently published conclusions from the 2024 paediatric strategy forum for

Assorted News from the Last Week: The U.S. Food and Drug Administration (FDA) approved FoundationOne®CDx as a companion diagnostic for Supporting Organization Member Day One

Assorted News from the Last Week: Pope Francis tells pediatric cancer patients they are ‘witnesses of hope.’ Unraveling the relationship between stress exposure and childhood

Assorted News from the Last Week: GLO-BNHL opens first sites of a multi-country platform trial that will offer multiple new treatments and a better chance

Assorted News from the Last Week: Spending package extends medicare telehealth flexibilities for three months and Gabriella Miller Kids First 2.0 reauthorization passes in standalone

Assorted News from the Last Week: Special Advocacy Call to Action: CAC2 Supporting Organization LLS is spearheading an effort and inviting all in the community

Assorted News from the Last Week: The simple act of asking young patients about their symptoms regularly during cancer treatment can help them get more

Assorted News from the Last Week: CAC2 Individual Member Jennifer Flowers writes compellingly about “When the National Drug Shortage Becomes Personal” for her. Published in

Assorted News from the Last Week: Last week the FDA reported that it is investigating reports of blood cancers — including life-threatening cases of myelodysplastic